MARKET

QNTM

QNTM

Quantum BioPharma Ltd
NASDAQ
1.610
-0.170
-9.55%
After Hours: 1.573 -0.037 -2.32% 19:52 11/13 EST
OPEN
1.750
PREV CLOSE
1.780
HIGH
1.770
LOW
1.600
VOLUME
87.53K
TURNOVER
--
52 WEEK HIGH
12.42
52 WEEK LOW
1.600
MARKET CAP
13.02M
P/E (TTM)
-0.2825
1D
5D
1M
3M
1Y
5Y
1D
Quantum BioPharma Non-GAAP EPS of -$0.06
Seeking Alpha · 1d ago
Quantum BioPharma Reports Approximately 91% Equity Increase as Lucid-MS Phase 2 Study Start-Up Begins
TipRanks · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 1d ago
Press Release: Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up
Dow Jones · 1d ago
Press Release: Quantum BioPharma achieve 91% -2-
Dow Jones · 1d ago
Quantum Biopharma Reports Unaudited September 30 Interim Financials
TipRanks · 2d ago
Quantum BioPharma Reports Shareholder Approvals and C$80.86 Private Placement
TipRanks · 2d ago
Quantum BioPharma (NASDAQ: QNTM) Reports Shareholder Meeting Results, Closes Private Placement Increasing Insider Voting Control
TipRanks · 3d ago
More
About QNTM
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Webull offers Quantum Biopharma Ltd stock information, including NASDAQ: QNTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNTM stock methods without spending real money on the virtual paper trading platform.